| Tumor evolution and drug response in patient-derived organoid models of bladder cancer SH Lee, W Hu, JT Matulay, MV Silva, TB Owczarek, K Kim, CW Chua, ... Cell 173 (2), 515-528. e17, 2018 | 658 | 2018 |
| Single luminal epithelial progenitors can generate prostate organoids in culture CW Chua, M Shibata, M Lei, R Toivanen, LMJ Barlow, SK Bergren, ... Nature cell biology 16 (10), 951-961, 2014 | 357 | 2014 |
| The role of gut microbiome in the pathogenesis of prostate cancer: a prospective, pilot study DM Golombos, A Ayangbesan, P O'Malley, P Lewicki, LM Barlow, ... Urology 111, 122-128, 2018 | 163 | 2018 |
| Long-term survival outcomes with intravesical docetaxel for recurrent nonmuscle invasive bladder cancer after previous bacillus Calmette-Guérin therapy LMJ Barlow, JM McKiernan, MC Benson The Journal of urology 189 (3), 834-839, 2013 | 133 | 2013 |
| Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysis LMJ Barlow, R Korets, M Laudano, M Benson, J McKiernan BJU international 106 (4), 489-492, 2010 | 120 | 2010 |
| Serum tumor markers in the evaluation of male germ cell tumors LMJ Barlow, GM Badalato, JM McKiernan Nature Reviews Urology 7 (11), 610-617, 2010 | 91 | 2010 |
| A phase I trial of intravesical nanoparticle albumin-bound paclitaxel in the treatment of bacillus Calmette-Guérin refractory nonmuscle invasive bladder cancer JM McKiernan, LMJ Barlow, MA Laudano, MJ Mann, DP Petrylak, ... The Journal of urology 186 (2), 448-451, 2011 | 89 | 2011 |
| Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin … JM McKiernan, DD Holder, RA Ghandour, LMJ Barlow, JJ Ahn, M Kates, ... The Journal of urology 192 (6), 1633-1638, 2014 | 87 | 2014 |
| Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non–muscle-invasive bladder cancer refractory to standard intravesical therapy MA Laudano, LJ Barlow, AM Murphy, DP Petrylak, M Desai, MC Benson, ... Urology 75 (1), 134-137, 2010 | 77 | 2010 |
| A single‐institution experience with induction and maintenance intravesical docetaxel in the management of non‐muscle‐invasive bladder cancer refractory to bacille Calmette … LM Barlow, J McKiernan, I Sawczuk, M Benson BJU international 104 (8), 1098-1102, 2009 | 52 | 2009 |
| The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experience LMJ Barlow, JM McKiernan, MC Benson World journal of urology 27, 331-335, 2009 | 51 | 2009 |
| Tumour diameter and decreased preoperative estimated glomerular filtration rate are independently correlated in patients with renal cell carcinoma NM Donin, LK Suh, LM Barlow, GW Hruby, J Newhouse, J McKiernan BJU international 109 (3), 379-383, 2012 | 45 | 2012 |
| A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2‐T4aN0‐N2M0 bladder cancer MS Wosnitzer, GW Hruby, AM Murphy, LJ Barlow, C Cordon‐Cardo, ... Cancer 118 (2), 358-364, 2012 | 35 | 2012 |
| SnapShot: prostate cancer LMJ Barlow, MM Shen Cancer cell 24 (3), 400-400. e1, 2013 | 28 | 2013 |
| Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein SL Woldu, LMJ Barlow, T Patel, GW Hruby, MC Benson, JM McKiernan Urology 76 (3), 639-642, 2010 | 28 | 2010 |
| The timing of radical cystectomy for bacillus Calmette-Guerin failure: comparison of outcomes and risk factors for prognosis CR Haas, LMJ Barlow, GM Badalato, GJ DeCastro, MC Benson, ... The Journal of Urology 195 (6), 1704-1709, 2016 | 27 | 2016 |
| The relationship between age at time of surgery and risk of biochemical failure after radical prostatectomy LMJ Barlow, GM Badalato, T Bashir, MC Benson, JM McKiernan BJU international 105 (12), 1646-1649, 2010 | 19 | 2010 |
| The correlation of media ranking's “best” hospitals and surgical outcomes following radical cystectomy for urothelial cancer D Lascano, JB Finkelstein, LMJ Barlow, D Kabat, A RoyChoudhury, ... Urology 86 (6), 1104-1114, 2015 | 15 | 2015 |
| Experience with newer intravesical chemotherapy for high-risk non-muscle-invasive bladder cancer LMJ Barlow, MC Benson Current urology reports 14, 65-70, 2013 | 15 | 2013 |
| The cytidine deaminase APOBEC3G contributes to cancer mutagenesis and clonal evolution in bladder cancer W Liu, KP Newhall, F Khani, LM Barlow, D Nguyen, L Gu, K Eng, ... Cancer Research 83 (4), 506-520, 2023 | 14 | 2023 |
